Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C48378
http://purl.obolibrary.org/obo/NCIT_C48378
|
|---|---|
| Preferred Name | Saracatinib |
| Definitions |
An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. |
|---|---|
| prefLabel | Saracatinib
|
| label | Saracatinib
|
| Has_Salt_Form | |
| PDQ_Closed_Trial_Search_ID | 453588
|
| code | C48378
|
| Has_Target | |
| prefixIRI | NCIT:C48378
|
| in_subset |
See more
See less
|
| Display_Name | Saracatinib
|
| Preferred_Name | Saracatinib
|
| FDA_UNII_Code | 9KD24QGH76
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C27H32ClN5O5
|
| Maps_To | Saracatinib
|
| CAS_Registry | 379231-04-6
|
| NSC Number | 735464
|
| NCI_Drug_Dictionary_ID | 453588
|
| Legacy Concept Name | AZD0530
|
| type | |
| ALT_DEFINITION | A substance being studied in the treatment of some types of cancer. AZD0530 blocks enzymes needed for cancer growth. It is a type of tyrosine kinase inhibitor.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 453588
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C2828242
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |